Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadoteric Acid in Non-Coronary MR Angiography
NCT00447889Phase 4Completed
- Sponsor
- Guerbet
- Start
- Mar 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadoterate meglumine in arterial occlusive disease (AOD), sponsored by Guerbet. Started Mar 2006; status: completed.
02
Drugs
gadoterate meglumine
03
Conditions
arterial occlusive disease (AOD)
Beyond the preview
Go deeper on NCT00447889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447889.